青瑶, 周环宇, 周超梦, 宋哲, 韦金华, 高剑波. 妊娠期糖尿病孕妇及2型糖尿病患者肠道菌群的特点分析[J]. 实用临床医药杂志, 2022, 26(17): 104-110. DOI: 10.7619/jcmp.20221338
引用本文: 青瑶, 周环宇, 周超梦, 宋哲, 韦金华, 高剑波. 妊娠期糖尿病孕妇及2型糖尿病患者肠道菌群的特点分析[J]. 实用临床医药杂志, 2022, 26(17): 104-110. DOI: 10.7619/jcmp.20221338
QING Yao, ZHOU Huanyu, ZHOU Chaomeng, SONG Zhe, WEI Jinhua, GAO Jianbo. Characteristics of gut microbiota of pregnant women with gestational diabetes mellitus and patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 104-110. DOI: 10.7619/jcmp.20221338
Citation: QING Yao, ZHOU Huanyu, ZHOU Chaomeng, SONG Zhe, WEI Jinhua, GAO Jianbo. Characteristics of gut microbiota of pregnant women with gestational diabetes mellitus and patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 104-110. DOI: 10.7619/jcmp.20221338

妊娠期糖尿病孕妇及2型糖尿病患者肠道菌群的特点分析

Characteristics of gut microbiota of pregnant women with gestational diabetes mellitus and patients with type 2 diabetes mellitus

  • 摘要:
    目的 探讨妊娠期糖尿病(GDM)孕妇及2型糖尿病(T2DM)患者肠道菌群的特点。
    方法 选取61例女性作为研究对象,将GDM孕妇纳入G组(n=15), 健康孕妇纳入N组(n=18), T2DM患者纳入D组(n=14), 健康女性纳入A组(n=14)。收集4组粪便样本,采用16S rDNA高通量基因测序技术进行测序,并对样品物种多样性分析、组间物种差异进行分析。
    结果 肠道菌群多样性分析显示, GDM孕妇与健康孕妇、T2DM患者与健康女性的Beta多样性比较,差异有统计学意义(P<0.05); 在Alpha多样性上, T2DM患者的菌群丰富度与健康女性比较,差异有统计学意义(P<0.05)。GDM孕妇与健康孕妇相比,肠道菌群中厚壁菌门(Firmicutes)丰度升高,拟杆菌门(Bacteroidetes)、毛螺菌属(Lachnobacterium)丰度降低,差异有统计学意义(P<0.05)。T2DM患者与健康女性相比,肠道菌群中考拉杆菌属(Phascolarctobacterium)的丰度升高,变形菌门(Proteobacteria)、放线菌门(Actinobacteria)、罗氏菌属(Roseburia)、苏黎世杆菌属(Turicibacter)、链球菌属(Streptococcus)、放线菌属(Actinomyces)、粪球菌属(Coprococcus)、变形杆菌属(Proteus)等人体共生菌丰度降低,差异有统计学意义(P<0.05)。
    结论 与健康女性相比, GDM孕妇和T2DM患者的肠道菌群均存在显著差异,该研究结果可为未来临床应用肠道微生态制剂治疗GDM和T2DM提供参考依据。

     

    Abstract:
    Objective To investigate the characteristics of gut microbiota in pregnant women with gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) patients.
    Methods A total of 61 women were selected as research objects, including GDM pregnant women in group G (n=15), healthy pregnant women in group N (n=18), T2DM patients in group D (n=14), and healthy women in group A (n=14). Four groups of fecal samples were collected and sequenced by 16S rDNA high-throughput sequencing technology. The species diversity of samples and species differences between groups were analyzed.
    Results Intestinal microbiota diversity analysis showed that there were statistically significant differences in Beta diversity between the GDM pregnant women and the healthy pregnant women as well as between the T2DM patients and the healthy women (P < 0.05). In terms of Alpha diversity, the microbiota richness of T2DM patients showed significant difference compared with that of the healthy women (P < 0.05). Compared with the healthy pregnant women, the abundance of Firmicutes in the gut microbiota of the GDM pregnant women was increased, while the abundance of Bacteroidetes and Lachnobacterium were decreased, and the differences were statistically significant (P < 0.05). Compared with the healthy women, the abundance of Phascolarctobacterium in the gut microbiota of T2DM patients was increased, while the abundance of human symbiotic bacteria such as Proteobacteria, Actinobacteria, Roseburia, Turicibacter, Streptococcus, Actinomyces, Coprococcus and Proteus were decreased, and the difference was statistically significant (P < 0.05).
    Conclusion Compared with the healthy women, the gut microbiota of pregnant women with GDM and T2DM patients are significantly different. The results of this study can provide a reference for the future clinical application of intestinal probiotics in the treatment of GDM and T2DM.

     

/

返回文章
返回